AzTrials
AzTrials

Non-specific Chronic Low Back PainICORNCT06669767

Behavioral Indicators of Pain Representation

An observational study of Non-specific Chronic Low Back Pain and Healthy Volunteer, run by Universite de Picardie Jules Verne at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to compare the postural response to the mental simulation of everyday situations identified as painful in participants with non-specific low back pain and healthy volunteers. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
How many people
34 participants
Where
1 siteFrance
Study dates
14 Nov 2024to 6 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: General population

Who may be able to join

  • Age between 18 and 55
  • Non-specific chronic low back pain for the concerned group

Who cannot join

  • Low back pain for 0 to 3 months
  • Unable to stand 1 minute without technical aid
  • Neurological, motor or cognitive know impairment
  • BMI > 30

Trial locations and contacts

1 site in 1 country.

France1 site
  • Université de Picardie Jules Verne

    Amiens, 80025

Other trials in France

About this study

The goal of this observational study is to compare the postural response to the mental simulation of everyday situations identified as painful in participants with non-specific low back pain and healthy volunteers.

The main questions it aims to answer are :

Do participants with low-back pain show reduced variability in center of pressure displacements compared with non-painful participants when faced with mental simulation of everyday situations identified as painful? Is the postural response correlated with the level of kinesiophobia? Participants will be faced to pictures of everyday situations identified as painful while several physiological measurements (posturography, electromyography, heart rate) are being recorded.

Keywords
Kinesiophobia, Low back pain, Posturography
Medical subject headings
Kinesiophobia, Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06669767
Study groupRoleWhat they receive
Non-specific chronic low back painParticipants with non-specific chronic low back pain (>3 months).
Control groupHealthy volunteers, without any low back pain.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Standard deviation of the position of the center of pressure on the anteroposterior axis (SD-COP-AP)

    Movements of the center of pressure (COP) are recorded using a force plate, and the SD-COP-AP is calculated after recording and is an indicator of the postural response.

    Measured: Baseline

Secondary outcomes (26)
  1. Mean position of the center of pressure on the anteroposterior axis (COP-AP)

    Measured: Baseline

  2. Mean position of the center of pressure on the mediolateral axis (COP-ML)

    Measured: Baseline

  3. Standard deviation of the position of the center of pressure on the mediolateral axis (SD-COP-ML)

    Measured: Baseline

  4. Sway length of the center of pressure on the anteroposterior axis (L-COP-AP)

    Measured: Baseline

  5. Sway length of the center of pressure on the mediolateral axis (L-COP-ML)

    Measured: Baseline

  6. Tibialis anterior muscle activity

    Measured by electromyography, RMS normalized to maximum voluntary contraction.

    Measured: Baseline

  7. Soleus muscle activity

    Measured by electromyography, RMS normalized to maximum voluntary contraction.

    Measured: Baseline

  8. Longissimus dorsi muscle activity

    Measured by electromyography, RMS normalized to maximum voluntary contraction.

    Measured: Baseline

  9. Co-activation (Soleus/Tibialis anterior)

    Measured: Baseline

  10. Coefficient of variation for muscle activity of tibialis anterior

    Measured: Baseline

  11. Coefficient of variation for muscle activity of soleus

    Measured: Baseline

  12. Coefficient of variation for muscle activity of longissimus dorsi

    Measured: Baseline

  13. Mean heart rate

    Measured: Baseline

  14. Mean RR interval

    Measured: Baseline

  15. Standard deviation of normal RR intervals (SDNN)

    Measured: Baseline

  16. Root mean square of successive R-R intervals (RMSSD)

    Measured: Baseline

  17. Power of very low frequency from frequency analysis (VLF)

    Measured: Baseline

  18. Power of low frequency from frequency analysis (LF)

    Measured: Baseline

  19. Power of high frequency from frequency analysis (HF)

    Measured: Baseline

  20. Ratio of LF/HF (post-frequency analysis)

    Measured: Baseline

  21. Tampa scale for kinesiophobia (TSK) score

    Kinesiophobia was evaluated with the Tampa Scale for Kinesiophobia (TSK), a self-administered questionnaire validated in French. The TSK measures the fear of movement and is used in various painful conditions. It includes 17 items evaluated on a 4-point Likert scale. The total score range is 17-68 and a high score indicates a greater fear of movement.

    Measured: Baseline

  22. Brief pain inventory (BPI) score

    Pain was assessed with the Brief Pain Inventory (BPI), a reliable self-administered questionnaire about pain severity (4 items) and interference with daily living (7 items) validated in French. Each item is evaluated on a numerical scale from 0 to 10. A high score indicates significant pain or significant interference in daily living.

    Measured: Baseline

  23. EQ-5D-5L questionnaire score

    The EQ-5D-5L is a standardized questionnaire used as a measure of health-related quality of life. The first part assesses 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression, on a five-level scale (no problem, slight problems, moderate problems, severe problems, unable to). The second part consist in a visual analogic scale about global health of the participant and provide a value from 0 to 100 with high value representing a good health.

    Measured: Baseline

  24. Fear-Avoidance Component Scale (FACS) score

    The fear-avoidance component scale is used to measure the major fear-avoidance signs in painful conditions. It includes 20 items evaluated on a 5-point Likert scale. The total score is from 0 to 100 with 5 severity levels: 0-20 subclinical, 21-40 low, 41-60 moderate, 61-80 severe, and extreme 81-100.

    Measured: Baseline

  25. Pain catastrophizing scale (PCS) score

    Catastrophism was evaluated with the pain catastrophizing scale. It includes 13 items evaluated on a 4-point Likert scale and divided into 3 dimensions: magnification, rumination, and helplessness. A high score corresponds to a high level of catastrophism. The total score ranges from 0 to 52 with a cut-off score of 30 for a significant catastrophism level.

    Measured: Baseline

  26. Hospital Anxiety and Depression scale (HAD) score

    The Hospital Anxiety and Depression scale (HAD) includes 14 items, 7 for anxiety and 7 for depression validated in French. Each item is rated from 0 to 3 and the scores for each dimension range from 0 to 21. Cut-off scores were established with 8-10 being uncertain symptomatology and above 10 being definite symptomatology.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2024
  2. Study start14 Nov 2024
  3. Primary completion6 Jun 2025
  4. Study completion6 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06669767
Sponsor's protocol ID
IRB00012476_2024_10_07_328
Acronym
ICOR
Status last verified
Aug 2025
First submitted
28 Oct 2024
Last updated
2 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Non-specific Chronic Low Back Pain and Healthy Volunteer, run by Universite de Picardie Jules Verne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Standard deviation of the position of the center of pressure on the anteroposterior axis (SD-COP-AP) (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in